To summarize with real numbers ...If anyone can correct me or add to make this more complete ...
The actual money in / money out at GUD might look something like this:
Bought Deals coming in: $75M+$180M+$87M+$230M = $572M
Sale of a PRV = $140M
Therefore, total incoming was roughly $712M (outside of operations)
We have $310M+ in cash, marketable securities and Investments
We paid and could pay a total of $180M for EXELON in 15/16 regions of the Americas
Have $40M in cash on hold with CRA/QRA - could go either way
Paid $365M for Grupo which gives us the strategic ROW set-up, Branded Generics Lab/R&D/manufacturing etc.
Therefore, Paid out $585M and have $310M as financial assets or $895M which can be explained via incoming cash of $712M plus any profits/cashflow from operations.
I think that's the right way to look at it (or close to it - excluding small items and covered loans). Not sure if I missed anything else.
It was the acquisition of Grupo and its successful roll-in that has us cashflow positive and bringing in a good chunk of cash annually to fund new programs.
A quick summary that tells you roughly where we are and how we got here.